- Home
- MLKN vs INVA Comparison
MLKN vs INVA Comparison
Compare MLKN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- INVA
- Stock Information
- Founded
- MLKN 1905
- INVA 1996
- Country
- MLKN United States
- INVA United States
- Employees
- MLKN N/A
- INVA N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- INVA Health Care
- Exchange
- MLKN Nasdaq
- INVA Nasdaq
- Market Cap
- MLKN 1.2B
- INVA 1.1B
- IPO Year
- MLKN N/A
- INVA 2004
- Fundamental
- Price
- MLKN $15.15
- INVA $18.28
- Analyst Decision
- MLKN
- INVA Buy
- Analyst Count
- MLKN 0
- INVA 5
- Target Price
- MLKN N/A
- INVA $35.60
- AVG Volume (30 Days)
- MLKN 445.6K
- INVA 709.6K
- Earning Date
- MLKN 12-17-2025
- INVA 11-06-2025
- Dividend Yield
- MLKN 4.95%
- INVA N/A
- EPS Growth
- MLKN N/A
- INVA N/A
- EPS
- MLKN N/A
- INVA 0.53
- Revenue
- MLKN $3,764,100,000.00
- INVA $370,229,000.00
- Revenue This Year
- MLKN $5.40
- INVA $7.98
- Revenue Next Year
- MLKN $3.96
- INVA $11.60
- P/E Ratio
- MLKN N/A
- INVA $33.97
- Revenue Growth
- MLKN 5.37
- INVA 12.02
- 52 Week Low
- MLKN $15.08
- INVA $16.52
- 52 Week High
- MLKN $25.96
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- MLKN 25.76
- INVA 54.74
- Support Level
- MLKN $16.51
- INVA $17.45
- Resistance Level
- MLKN $17.77
- INVA $18.31
- Average True Range (ATR)
- MLKN 0.47
- INVA 0.49
- MACD
- MLKN -0.09
- INVA 0.16
- Stochastic Oscillator
- MLKN 4.07
- INVA 69.23
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.